Some patients with schizophrenia may experience residual symptoms when treated with antipsychotics, due in part to their side effects. This analysis aims to examine both short-term improvement and residual symptoms of prescribed medication.
The efficacy of brodalumab by self-identified gender in patients with nail or scalp psoriasis is investigated.
Researchers are exploring affective lability as a therapeutic target for bipolar disorder, but limited evidence exists on its prevalence and impact among people with schizophrenia and other psychosis spectrum disorders.
With people who have major psychiatric disorders being more likely to have comorbidities which could lead to worse results concerning COVID-19, researchers using a US database assessed the odds of testing positive for COVID-19, as well as mortality from COVID-19.
Teens who use alcohol, cannabis, tobacco, or illegal drugs are more likely to develop life-long substance abuse disorder than those who start at a later age.
While past research has found that young smokers are more likely to attempt to quit smoking, findings regarding age and success of quitting is conflicted. This study examines the degree to which smoker age is related to making quit attempts and quit success.
The researchers assessed the effectiveness and implementation of stepped collaborative care intervention for posttraumatic stress disorder.
The researchers conducted genome-wide association studies of PTSD in military veterans to explore the genetic association with the common comorbidities of depression and anxiety.
This study explores the rate of suicidality in children and youth with epilepsy and psychiatric comorbidities.
This study aims to characterize rates of clinically documented “diseases of despair” over the last decade and identify sociodemographic risk factors.
